All In MedTech

FDA Clearance Tracker · P000039-S012

AMPLATZER SEPTAL OCCLUDER AND AMPLATZER TORQVUE DELIVERY AND EXCHANGE SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 25, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P000039-S012
Device name
AMPLATZER SEPTAL OCCLUDER AND AMPLATZER TORQVUE DELIVERY AND EXCHANGE SYSTEM
Applicant location
St. Paul, MN
Received
Nov 14, 2005
Decided
Apr 25, 2007
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P000039

Device type

Device class
Class III

Every decision under product code MAE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A NEW DELIVERY SYSTEM AND MODIFICATIONS TO THE DEVICE PACKAGING. THE DEVICES, WITH THE MODIFIED DELIVERY SYSTEMS, WILL BE MARKETED UNDER THE TRADE NAME TORQVUE DELIVERY AND EXCHANGE SYSTEMS.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.